Roger's responsibilities will include identifying and establishing strategic business partnerships and expanding Eden Biodesign's offer to the large US biopharmaceutical sector. He joins Eden Biodesign from Cytovance Biologics, where he has held the position of Vice President, Sales and Business Development since 2004, assuming responsibility for the entire commercial function. During this period he built the company's infrastructure, marketing programs and the initial customer base. At KBI BioPharma, a start-up contract biomanufacturing company, Roger played an active role in securing funding and building revenues. His responsibilities also included identifying and establishing strategic business partnerships and establishing new business relationships. Prior to that he was Vice President, Business Development at Diosynth where he had global responsibility and previously headed North American sales and marketing for Lonza Biologics.

"I am excited about joining the highly experienced Eden Biodesign team," Roger Lias said, "this position will allow me to contribute at a high level using the skills, experience and relationships I've acquired over the course of my career to establish a US based operation and significantly strengthen Eden Biodesign's position in the North American market."